Table 5.
Control (n = 10) | Cisplatin treated (n = 10) | PRP treated (n = 10) | F | p | |
---|---|---|---|---|---|
Feret’s diameter of the renal corpuscle | |||||
Min.–Max. | 105.58–130.23 | 130.71–191.26 | 110.66–150.13 | 20.712* | <0.001* |
Mean ± SD. | 117.49 ± 9.04 | 161.96 ± 23.79 | 126.15 ± 12.55 | ||
Median | 120.21 | 167.82 | 125.79 | ||
p1 | <0.001* | 0.473 | |||
p2 | <0.001* | ||||
Perimeter of the renal corpuscle | |||||
Min.–Max. | 296.9–308.4 | 313.3–397.3 | 298.2–304.8 | 42.493* | <0.001* |
Mean ± SD. | 302.1 ± 3.46 | 356.9 ± 26.18 | 302.4 ± 2.27 | ||
Median | 302.4 | 360.1 | 303.2 | ||
p1 | <0.001* | 0.999 | |||
p2 | <0.001* | ||||
Percentage of the surface area of Bowman’s space | |||||
Min.–Max. | 13.09–21.38 | 28.11–77.19 | 13.09–21.38 | 42.248* | <0.001* |
Mean ± SD. | 15.89 ± 2.55 | 45.94 ± 14.35 | 15.31 ± 2.38 | ||
Median | 14.64 | 43.73 | 14.59 | ||
p1 | <0.001* | 0.987 | |||
p2 | <0.001* | ||||
Circularity of the renal corpuscle | |||||
Min.–max. | 0.967–0.990 | 0.877–0.910 | 0.959–0.975 | 308.106* | <0.001* |
Mean ± SD. | 0.973 ± 0.007 | 0.896 ± 0.010 | 0.967 ± 0.006 | ||
Median | 0.971 | 0.900 | 0.969 | ||
p1 | <0.001* | 0.275 | |||
p2 | <0.001* | ||||
Basement membrane thickness in micrometer | |||||
Min.–Max. | 0.77–0.97 | 1.87–2.15 | 0.97–1.97 | 33.952* | <0.001* |
Mean ± SD. | 0.87 ± 0.09 | 2.03 ± 0.11 | 1.47 ± 0.36 | ||
Median | 0.87 | 2.05 | 1.44 | ||
p1 | <0.001* | 0.003* | |||
p2 | 0.005* |
SD, standard deviation
F, F for one-way ANOVA test, pairwise comparison bet. each 2 groups was done using post hoc test (Tukey)
p, p value for comparing between the three studied groups
p1, p value for comparing between control and each other groups
p2, p value for comparing between cisplatin treated and PRP treated
*Statistically significant at p ≤ 0.05